Spots Global Cancer Trial Database for perifosine
Every month we try and update this database with for perifosine cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Trial of Two Schedules of Perifosine for Patients With Solid Tumors or Lymphomas | NCT00389077 | Tumors Lymphomas | Perifosine | 18 Years - | AEterna Zentaris | |
| Perifosine in Treating Patients With Metastatic or Recurrent Malignant Melanoma | NCT00053781 | Melanoma (Skin) | perifosine | 18 Years - 120 Years | Canadian Cancer Trials Group | |
| A Phase II Trial of Perifosine Following Tyrosine Kinase Inhibitor (TKI) - Failure in Patients With Renal Cancer | NCT00448721 | Renal Cell Carc... | Perifosine | 18 Years - | AEterna Zentaris | |
| Perifosine in Patients With Relapsed/Refractory Waldenstrom's Macroglobulinemia | NCT00422656 | Waldenstrom's M... | Perifosine | 18 Years - | Dana-Farber Cancer Institute | |
| Study of Single Agent Perifosine for Recurrent Pediatric Solid Tumors | NCT00776867 | Solid Tumors | perifosine | - 21 Years | Memorial Sloan Kettering Cancer Center | |
| Perifosine in Treating Patients With Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer | NCT00059982 | Pancreatic Canc... | perifosine | 18 Years - | National Cancer Institute (NCI) | |
| A Trial of Perifosine in Patients With Chemo-Insensitive Sarcomas | NCT00401388 | Chondrosarcomas Alveolar Soft P... Extra Skeletal ... | Perifosine Loperamide Allopurinol Antiemetics | 13 Years - | AEterna Zentaris | |
| Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer | NCT01097018 | Colorectal Canc... | Capecitabine Perifosine Placebo | 18 Years - | AEterna Zentaris | |
| Perifosine in Treating Patients With Recurrent, Refractory, Locally Advanced, or Metastatic Breast Cancer | NCT00054145 | Breast Cancer | perifosine | 18 Years - | University Health Network, Toronto | |
| Phase I Study of Perifosine + Lenalidomide and Dexamethasone for Patients With Multiple Myeloma | NCT00415064 | Multiple Myelom... | Perifosine Lenalidomide Dexamethasone | 18 Years - | AEterna Zentaris | |
| Perifosine and Docetaxel in Patients With Relapsed Epithelial Ovarian Cancer | NCT00431054 | Ovarian Cancer | Perifosine Docetaxel | 18 Years - | M.D. Anderson Cancer Center | |
| Safety & Efficacy Study of Perifosine + Bortezomib +/- Dexamethasone for Multiple Myeloma Patients | NCT00401011 | Multiple Myelom... Multiple Myelom... | Perifosine Bortezomib Dexamethasone | 18 Years - | AEterna Zentaris | |
| Assessment of Efficacy and Safety of Perifosine, Bortezomib and Dexamethasone in Multiple Myeloma Patients | NCT01002248 | Multiple Myelom... | Perifosine Perifosine Plac... Bortezomib Dexamethasone | 18 Years - | AEterna Zentaris | |
| Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma | NCT00053794 | Endometrial Can... Sarcoma | perifosine | 18 Years - 120 Years | Canadian Cancer Trials Group | |
| Phase I Trial of Paclitaxel With Perifosine | NCT00399126 | Neoplasms | Perifosine Paclitaxel | 18 Years - | AEterna Zentaris | |
| A Food Effect and QTc Study of Perifosine in Patients With Advanced Malignancies | NCT01224730 | Cancer | perifosine | 18 Years - | AEterna Zentaris | |
| Perifosine + Sunitinib Malate for Patients With Advanced Cancers | NCT00399152 | Renal Cancer GIST | Perifosine Sunitinib Malat... | 18 Years - | AEterna Zentaris | |
| Open Label Trial of Perifosine in Patients Currently Being Treated on Perifosine Trials in Solid Tumors or Multiple Myeloma | NCT00847366 | Non Small Cell ... Solid Tumors Metastatic Brea... Sarcomas | Perifosine Trastuzumab Tamoxifen | 18 Years - | AEterna Zentaris | |
| A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer | NCT00399789 | Non Small Cell ... | Perifosine | 18 Years - | AEterna Zentaris | |
| A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer | NCT00399789 | Non Small Cell ... | Perifosine | 18 Years - | AEterna Zentaris | |
| Efficacy of Perifosine Alone and in Combination With Dexamethasone for Patients With Multiple Myeloma | NCT00375791 | Multiple Myelom... | perifosine dexamethasone | 18 Years - | AEterna Zentaris | |
| Study of Perifosine + Capecitabine for Colon Cancer Patients | NCT01048580 | Colon Cancer | Perifosine Capecitabine | 18 Years - | AEterna Zentaris | |
| A Phase II Study of Perifosine in Patients With Relapsed/Refractory Waldenström's Macroglobulinemia | NCT00398710 | Waldenström's M... | Perifosine | 18 Years - | AEterna Zentaris | |
| Study of Single Agent Perifosine for Recurrent Pediatric Solid Tumors | NCT00776867 | Solid Tumors | perifosine | - 21 Years | Memorial Sloan Kettering Cancer Center | |
| Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma | NCT01051557 | Adult Anaplasti... Adult Anaplasti... Adult Diffuse A... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Adult Oligodend... Recurrent Adult... | Laboratory Biom... Perifosine Temsirolimus Therapeutic Con... | 18 Years - | National Cancer Institute (NCI) | |
| Ph II Study of Perifosine Plus Gleevec for Patients With GIST | NCT00455559 | Gastrointestina... | Perifosine Imatinib Mesyla... | 18 Years - | AEterna Zentaris | |
| Perifosine in Treating Patients With Advanced Solid Tumors | NCT00005794 | Unspecified Adu... | perifosine | 18 Years - 120 Years | University of Wisconsin, Madison | |
| Study of Perifosine + Capecitabine for Colon Cancer Patients | NCT01048580 | Colon Cancer | Perifosine Capecitabine | 18 Years - | AEterna Zentaris | |
| Perifosine in Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | NCT00873457 | Chronic Lymphoc... Small Lymphocyt... | perifosine | 18 Years - | Duke University | |
| Study of Single Agent Perifosine for Recurrent Pediatric Solid Tumors | NCT00776867 | Solid Tumors | perifosine | - 21 Years | Memorial Sloan Kettering Cancer Center | |
| Perifosine in Treating Patients With Metastatic, Androgen-Independent Prostate Cancer | NCT00060437 | Prostate Cancer | perifosine | 18 Years - | National Cancer Institute (NCI) | |
| Perifosine With Temsirolimus for Recurrent Pediatric Solid Tumors | NCT01049841 | Pediatric Solid... | perifosine + te... | - 21 Years | Memorial Sloan Kettering Cancer Center | |
| Phase I Perifosine and Gemcitabine Study | NCT00398697 | Neoplasms | Perifosine Gemcitabine | 18 Years - | AEterna Zentaris | |
| Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma | NCT01051557 | Adult Anaplasti... Adult Anaplasti... Adult Diffuse A... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Adult Oligodend... Recurrent Adult... | Laboratory Biom... Perifosine Temsirolimus Therapeutic Con... | 18 Years - | National Cancer Institute (NCI) | |
| Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer | NCT01097018 | Colorectal Canc... | Capecitabine Perifosine Placebo | 18 Years - | AEterna Zentaris | |
| Perifosine in Treating Patients With Metastatic or Recurrent Malignant Melanoma | NCT00053781 | Melanoma (Skin) | perifosine | 18 Years - 120 Years | Canadian Cancer Trials Group | |
| A Food Effect and QTc Study of Perifosine in Patients With Advanced Malignancies | NCT01224730 | Cancer | perifosine | 18 Years - | AEterna Zentaris | |
| Phase I Trial of Docetaxel With Perifosine | NCT00399087 | Neoplasms | Perifosine Docetaxel Prednisone | 18 Years - | AEterna Zentaris | |
| Ph II Study of Perifosine for Patients With Carcinoma of the Kidney | NCT00498966 | Kidney Cancer | Perifosine | 18 Years - | AEterna Zentaris | |
| Phase II Study of Perifosine in Patients With Refractory and Relapsed Leukemia | NCT00391560 | Leukemia | perifosine | 18 Years - | AEterna Zentaris |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
